BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

75 related articles for article (PubMed ID: 1906639)

  • 1. [Prevalence and features of pre-B-cell acute lymphoblastic leukemia in Mexico: description of 9 patients].
    Lobato-Mendizábal E; Ruiz-Argüelles GJ
    Sangre (Barc); 1991 Feb; 36(1):1-5. PubMed ID: 1906639
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical relevance of CD10 expression in childhood ALL. The Italian Association for Pediatric Hematology and Oncology (AIEOP).
    Consolini R; Legitimo A; Rondelli R; Guguelmi C; Barisone E; Lippi A; Cantù-Rajnoldi A; Aricò M; Conter V; Cocito MG; Putti MC; Pession A; Masera G; Biondi A; Basso G
    Haematologica; 1998 Nov; 83(11):967-73. PubMed ID: 9864914
    [TBL] [Abstract][Full Text] [Related]  

  • 3. B-lineage acute lymphoblastic leukemia of childhood. An institutional experience.
    Rivera-Luna R; Cardenas-Cardos R; Leal-Leal C; Navarro-Alegría I; Meza-Coria C; Gómez-Martínez R; Vega-Vega L
    Arch Med Res; 1997; 28(2):233-9. PubMed ID: 9204615
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Immunophenotyping of acute lymphoblastic leukemia in Mexican children].
    Paredes-Aguilera R; Romero-Guzmán L; López-Santiago N; Bravo-Lindoro A; Correa-González C; Joly-Linero R; Nieto-Martínez S; del Campo-Martínez A
    Sangre (Barc); 1999 Jun; 44(3):188-94. PubMed ID: 10481579
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Minimal residual disease values discriminate between low and high relapse risk in children with B-cell precursor acute lymphoblastic leukemia and an intrachromosomal amplification of chromosome 21: the Austrian and German acute lymphoblastic leukemia Berlin-Frankfurt-Munster (ALL-BFM) trials.
    Attarbaschi A; Mann G; Panzer-Grümayer R; Röttgers S; Steiner M; König M; Csinady E; Dworzak MN; Seidel M; Janousek D; Möricke A; Reichelt C; Harbott J; Schrappe M; Gadner H; Haas OA
    J Clin Oncol; 2008 Jun; 26(18):3046-50. PubMed ID: 18565891
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Acute lymphatic leukemia with pre-B-cell characteristics].
    Sauerbrey A; Häfer R; Zintl F
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1989; 116(2):219-26. PubMed ID: 2475400
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mixed lineage leukemia-rearranged childhood pro-B and CD10-negative pre-B acute lymphoblastic leukemia constitute a distinct clinical entity.
    Attarbaschi A; Mann G; König M; Steiner M; Strehl S; Schreiberhuber A; Schneider B; Meyer C; Marschalek R; Borkhardt A; Pickl WF; Lion T; Gadner H; Haas OA; Dworzak MN
    Clin Cancer Res; 2006 May; 12(10):2988-94. PubMed ID: 16707593
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Poor outcome for children and adolescents with progressive disease or relapse of lymphoblastic lymphoma: a report from the berlin-frankfurt-muenster group.
    Burkhardt B; Reiter A; Landmann E; Lang P; Lassay L; Dickerhoff R; Lakomek M; Henze G; von Stackelberg A
    J Clin Oncol; 2009 Jul; 27(20):3363-9. PubMed ID: 19433688
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of glutathione S-transferase gene deletion on early relapse in childhood B-precursor acute lymphoblastic leukemia.
    Takanashi M; Morimoto A; Yagi T; Kuriyama K; Kano G; Imamura T; Hibi S; Todo S; Imashuku S
    Haematologica; 2003 Nov; 88(11):1238-44. PubMed ID: 14607752
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression of CD10, CD19 and CD34 markers in bone marrow samples of children with precursor B-cell acute lymphoblastic leukemia in clinical and hematological remission.
    Cáp J; Babusíková O; Kaiserová E; Jamárik M
    Neoplasma; 1998; 45(4):231-6. PubMed ID: 9890666
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Granular CALLA-positive acute lymphoblastic leukemia].
    De Salvo Cardullo L; Weir Madina J; Gómez Sánchez O; Plumacher Z; Salas D
    Invest Clin; 1990; 31(3):153-61. PubMed ID: 2101643
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Late intensification chemotherapy has not improved the results of intensive chemotherapy in adult acute lymphoblastic leukemia. Results of a prospective multicenter randomized trial (PETHEMA ALL-89). Spanish Society of Hematology.
    Ribera JM; Ortega JJ; Oriol A; Fontanillas M; Hernández-Rivas JM; Brunet S; García-Conde J; Maldonado J; Zuazu J; Gardella S; Besalduch J; León P; Macià J; Domingo-Albós A; Feliu E; San Miguel JF
    Haematologica; 1998 Mar; 83(3):222-30. PubMed ID: 9573676
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Transitional pre-B-cell acute lymphoblastic leukemia of childhood is associated with favorable prognostic clinical features and an excellent outcome: a Pediatric Oncology Group study.
    Koehler M; Behm FG; Shuster J; Crist W; Borowitz M; Look AT; Head D; Carroll AJ; Land V; Steuber P
    Leukemia; 1993 Dec; 7(12):2064-8. PubMed ID: 8255107
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic impact of age in children and adolescents with acute lymphoblastic leukemia: data from the trials ALL-BFM 86, 90, and 95.
    Möricke A; Zimmermann M; Reiter A; Gadner H; Odenwald E; Harbott J; Ludwig WD; Riehm H; Schrappe M
    Klin Padiatr; 2005; 217(6):310-20. PubMed ID: 16307416
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mixed chimerism in the B cell lineage is a rapid and sensitive indicator of minimal residual disease in bone marrow transplant recipients with pre-B cell acute lymphoblastic leukemia.
    Zetterquist H; Mattsson J; Uzunel M; Näsman-Björk I; Svenberg P; Tammik L; Bayat G; Winiarski J; Ringdén O
    Bone Marrow Transplant; 2000 Apr; 25(8):843-51. PubMed ID: 10808205
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic value of karyotypic analysis in children and adults with high-risk acute lymphoblastic leukemia included in the PETHEMA ALL-93 trial.
    Ribera JM; Ortega JJ; Oriol A; Granada I; Hernández-Rivas JM; Parody R; Bethencourt C; Rivas C; Bastida P; del Potro E; González-Valentín ME; Moreno MJ; Besalduch J; Fernández-Calvo J; Tormo M; Arias J; Molinés A; Sanz MA; Maldonado J; Millá F; Feliu E; San Miguel JF;
    Haematologica; 2002 Feb; 87(2):154-66. PubMed ID: 11836166
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High nerve growth factor receptor (p75NTR) expression is a favourable prognostic factor in paediatric B cell precursor-acute lymphoblastic leukaemia.
    Troeger A; Gudowius S; Escherich G; den Boer ML; Glouchkova L; Ackermann B; Meisel R; Laws HJ; Groeger M; Wessalowski R; Willers R; Harbott J; Pieters R; Goebel U; Janka-Schaub GE; Hanenberg H; Dilloo D
    Br J Haematol; 2007 Nov; 139(3):450-7. PubMed ID: 17910636
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Complicated but successful treatment of a patient with ataxia telangiectasia and pre-B-acute lymphoblastic leukemia.
    Brummel B; Bernbeck B; Schneider DT
    Klin Padiatr; 2010 Nov; 222(6):391-4. PubMed ID: 21058227
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Translocation (14;14)(q11;q32) with simultaneous involvement of the IGH and CEBPE genes in B-lineage acute lymphoblastic leukemia.
    Han Y; Xue Y; Zhang J; Wu Y; Pan J; Wang Y; Shen J; Dai H; Bai S
    Cancer Genet Cytogenet; 2008 Dec; 187(2):125-9. PubMed ID: 19027493
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Improved therapy for children with acute lymphoblastic leukemia.
    Komada Y; Sakurai M
    Biomed Pharmacother; 1996; 50(3-4):132-9. PubMed ID: 8881369
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.